Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

被引：0
|
作者：
Naglaa F. A. Youssef
Mohamed El Kassas
Amany Farag
Ashley Shepherd
机构：
[1] Cairo University,Faculty of Nursing
[2] Helwan University,Faculty of Medicine
[3] University of Stirling,Faculty of Health Sciences and Sport
来源：
BMC Gastroenterology | / 17卷
关键词：
Directly acting antivirals-DAAs; Health related quality of life; Social support; Patient reported outcomes (PROs); Hepatitis C Virus antiviral therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt
    Youssef, Naglaa F. A.
    El Kassas, Mohamed
    Farag, Amany
    Shepherd, Ashley
    BMC GASTROENTEROLOGY, 2017, 17
  • [2] Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Gane, Edward
    Jacobson, Ira M.
    Lawitz, Eric
    Nelson, David
    Gerber, Lynn
    Nader, Fatema
    Hunt, Sharon
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (08) : 1349 - +
  • [3] Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China An observational study
    Xu, Xiao-Wei
    Wu, Xiao-Xin
    Chen, Ke-Da
    Chen, Da-Zhi
    Ou, Hui-Lin
    Su, Jun-Wei
    Yu, Hai-Ying
    Yao, Hang-Ping
    Li, Lan-Juan
    MEDICINE, 2018, 97 (38)
  • [4] Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
    Akio Miyasaka
    Yuichi Yoshida
    Akiko Suzuki
    Yasuhiro Takikawa
    Quality of Life Research, 2021, 30 : 3501 - 3509
  • [5] Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
    Miyasaka, Akio
    Yoshida, Yuichi
    Suzuki, Akiko
    Takikawa, Yasuhiro
    QUALITY OF LIFE RESEARCH, 2021, 30 (12) : 3501 - 3509
  • [6] Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies - A prospective observational study of 136 patients
    Torres, H. A.
    Economides, M. P.
    Kyvernitakis, A.
    Mahale, P.
    Hosry, J.
    Jiang, Y.
    Kaseb, A.
    Raad, I.
    Granwehr, B. P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S506 - S506
  • [7] Effect of Interferon-α Treatment of Chronic Hepatitis C on Health-Related Quality of Life
    Christine M. Hunt
    Jason A. Dominitz
    Barbara Philips Bute
    Bradford Waters
    Umberto Blasi
    Diane M. Williams
    Digestive Diseases and Sciences, 1997, 42 : 2482 - 2486
  • [8] Effect of interferon-α treatment of chronic hepatitis C on health-related quality of life
    Hunt, CM
    Dominitz, JA
    Bute, BP
    Waters, B
    Blasi, U
    Williams, DM
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (12) : 2482 - 2486
  • [9] Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment
    Sinakos, E.
    Gigi, E.
    Lalla, T.
    Bellou, A-L
    Sykja, A.
    Orphanou, E.
    Vrettou, E.
    Tsapas, V
    Raptopoulou, M.
    HIPPOKRATIA, 2010, 14 (02) : 122 - 125
  • [10] Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study
    Torres, Harrys A.
    Economides, Minas P.
    Angelidakis, Georgios
    Hosry, Jeff
    Kyvernitakis, Andreas
    Mahale, Parag
    Jiang, Ying
    Miller, Ethan
    Blechacz, Boris
    Naing, Aung
    Samaniego, Felipe
    Kaseb, Ahmed
    Raad, Issam I.
    Granwehr, Bruno P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (02): : 250 - 257
12345